Viracta Therapeutics Winds Down Operations, Terminates Employees

Dow Jones

Feb 06

By Sabela Ojea

Viracta Therapeutics plans to wind down operations and has terminated its employees.

The clinical-stage precision oncology company on Wednesday said that it named Chief Executive Craig Jalbert, who took over the top job last March, as the sole member of the board to implement the wind down.

The company said that it's also exploring potential strategic alternatives for its development programs.

The decision comes about a month after the company said its board had initiated a process to explore strategic options, and that it had decided to close a Phase 2 trial of Naval-1, which was evaluating the drug as a treatment for certain lymphoma patients, to maximize its cash runway.

In November, the company said it was cutting its workforce and reducing the size of the board to six from 10.

Write to Sabela Ojea at sabela.ojea@wsj.com; @sabelaojeaguix

(END) Dow Jones Newswires

February 05, 2025 17:25 ET (22:25 GMT)

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2509250337"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2509250337\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2509250337?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-02-06 06:25","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2509250337","market":"us","top_or_hot":-1,"title":"Viracta Therapeutics Winds Down Operations, Terminates Employees","media":"Dow Jones","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<pre>\n \n</pre>\n<p>\n  By Sabela Ojea \n</p>\n<pre>\n \n</pre>\n<p>\n  Viracta <a href=\"https://laohu8.com/S/LENZ\">Therapeutics</a> plans to wind down operations and has terminated its employees. \n</p>\n<p>\n  The clinical-stage precision oncology company on Wednesday said that it named Chief Executive Craig Jalbert, who took over the top job last March, as the sole member of the board to implement the wind down. \n</p>\n<p>\n  The company said that it's also exploring potential strategic alternatives for its development programs. \n</p>\n<p>\n  The decision comes about a month after the company said its board had initiated a process to explore strategic options, and that it had decided to close a Phase 2 trial of Naval-1, which was evaluating the drug as a treatment for certain lymphoma patients, to maximize its cash runway. \n</p>\n<p>\n  In November, the company said it was cutting its workforce and reducing the size of the board to six from 10. \n</p>\n<pre>\n \n</pre>\n<p>\n  Write to Sabela Ojea at sabela.ojea@wsj.com; @sabelaojeaguix \n</p>\n<pre>\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  February 05, 2025 17:25 ET (22:25 GMT)\n</p>\n<p>\n  Copyright (c) 2025 Dow Jones &amp; Company, Inc.\n</p>\n</font>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Viracta Therapeutics Winds Down Operations, Terminates Employees</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nViracta Therapeutics Winds Down Operations, Terminates Employees\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2025-02-06 06:25</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<font class=\"NormalMinus1\" face=\"Arial\">\n<pre>\n \n</pre>\n<p>\n  By Sabela Ojea \n</p>\n<pre>\n \n</pre>\n<p>\n  Viracta <a href=\"https://laohu8.com/S/LENZ\">Therapeutics</a> plans to wind down operations and has terminated its employees. \n</p>\n<p>\n  The clinical-stage precision oncology company on Wednesday said that it named Chief Executive Craig Jalbert, who took over the top job last March, as the sole member of the board to implement the wind down. \n</p>\n<p>\n  The company said that it's also exploring potential strategic alternatives for its development programs. \n</p>\n<p>\n  The decision comes about a month after the company said its board had initiated a process to explore strategic options, and that it had decided to close a Phase 2 trial of Naval-1, which was evaluating the drug as a treatment for certain lymphoma patients, to maximize its cash runway. \n</p>\n<p>\n  In November, the company said it was cutting its workforce and reducing the size of the board to six from 10. \n</p>\n<pre>\n \n</pre>\n<p>\n  Write to Sabela Ojea at sabela.ojea@wsj.com; @sabelaojeaguix \n</p>\n<pre>\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  February 05, 2025 17:25 ET (22:25 GMT)\n</p>\n<p>\n  Copyright (c) 2025 Dow Jones &amp; Company, Inc.\n</p>\n</font>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4139","symbol_name":"生物科技","start_time":0,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2509250337","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2509250337","pubTimestamp":1738794300,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"Viracta Therapeutics plans to wind down operations and has terminated its employees.The clinical-stage precision oncology company on Wednesday said that it named Chief Executive Craig Jalbert, who took over the top job last March, as the sole member of the board to implement the wind down.The company said that it's also exploring potential strategic alternatives for its development programs.The decision comes about a month after the company said its board had initiated a process to explore strategic options, and that it had decided to close a Phase 2 trial of Naval-1, which was evaluating the drug as a treatment for certain lymphoma patients, to maximize its cash runway.In November, the company said it was cutting its workforce and reducing the size of the board to six from 10.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4139":"生物科技","LENZ":"Therapeutics"},"translate_title":"Viracta Therapeutics缩减业务并解雇员工","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"LENZ":1,"VIRX":0.9},"content_text":"By Sabela Ojea \n\n\n \n\n\n  Viracta Therapeutics plans to wind down operations and has terminated its employees. \n\n\n  The clinical-stage precision oncology company on Wednesday said that it named Chief Executive Craig Jalbert, who took over the top job last March, as the sole member of the board to implement the wind down. \n\n\n  The company said that it's also exploring potential strategic alternatives for its development programs. \n\n\n  The decision comes about a month after the company said its board had initiated a process to explore strategic options, and that it had decided to close a Phase 2 trial of Naval-1, which was evaluating the drug as a treatment for certain lymphoma patients, to maximize its cash runway. \n\n\n  In November, the company said it was cutting its workforce and reducing the size of the board to six from 10. \n\n\n \n\n\n  Write to Sabela Ojea at sabela.ojea@wsj.com; @sabelaojeaguix \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  February 05, 2025 17:25 ET (22:25 GMT)\n\n\n  Copyright (c) 2025 Dow Jones & Company, Inc.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-2","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":true,"code":"91000000","status":"200"}}}